Literature DB >> 7855783

Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S.

V De Stefano1, G Leone, S Mastrangelo, A Tripodi, F Rodeghiero, G Castaman, T Barbui, G Finazzi, B Bizzi, P M Mannucci.   

Abstract

The clinical history of 238 patients with inherited thrombophilia (AT III = 94, PC = 103, PS = 41) was analyzed retrospectively at diagnosis and in the follow-up period after diagnosis. At diagnosis 129 patients (54%) had suffered from thrombosis, with a recurrence rate of 48%. The most frequent onset manifestation was deep vein thrombosis of lower limbs (58%). Thrombotic history started before 40 in 80% of the cases. Forty-nine percent of the venous thromboses were preceded by a triggering event, in most cases pregnancy (17%) and surgery (12%). After diagnosis, follow-up lasted a total of 1,113 pt-years. A policy of short-term prophylaxis during risk situations for all patients and long-term prophylaxis in symptomatic patients failed to prevent venous thrombotic episodes (diagnosed by objective methods) in 4 previously asymptomatic subjects and recurrence in 7 previously symptomatic subjects. After knowledge of the patients' diagnosis the incidence of venous thrombosis/100 pt-years was reduced as compared before diagnosis as total episodes (onset+recurrencies) (1.0 vs 1.9), onset episodes (0.7 vs 1.3) and recurrent episodes (1.3 vs 4.8), even though the differences were not statistically significant. However most of the venous thromboses occurred at a more advanced age (67% after 40 years) and without any apparent cause (83%), at significant variance with the period preceding the diagnosis; in particular the incidence of venous thrombotic onset in patients younger than 40 passed from 1.3/100 pt-years to 0.2/100 pt-years. In 6 recurrences after diagnosis a poor compliance for antithrombotic treatment was recognized.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7855783

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  Evaluation of Hypercoagulable States.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998       Impact factor: 2.300

Review 2.  Inherited thrombophilia: memorandum from a joint WHO/International Society on Thrombosis and Haemostasis meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  [Pulmonary embolism with paradoxical coronary and peripheral arterial embolization. Increased risk of thrombosis caused by contraception with desogestrel and ethinylestradiol?].

Authors:  J Brockmeier; J Carlsson; S Miketic; R Meierhenrich; E Sorges; L Obergassel; U Tebbe
Journal:  Med Klin (Munich)       Date:  1997-01-15

Review 4.  Inherited risk factors for venous thromboembolism.

Authors:  Ida Martinelli; Valerio De Stefano; Pier M Mannucci
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

5.  Recurrent acute stent thrombosis associated with protein C and S deficiencies.

Authors:  Gurkan Acar; Abdullah Dogan; Ahmet Altinbas; Yasin Turker
Journal:  Int J Cardiovasc Imaging       Date:  2006-02-25       Impact factor: 2.357

6.  Benign intracranial hypertension associated to blood coagulation derangements.

Authors:  Domenico De Lucia; Marisanta Napolitano; Pierpaolo Di Micco; Alferio Niglio; Andrea Fontanella; Giuseppe Di lorio
Journal:  Thromb J       Date:  2006-12-24

7.  Deficiencies of proteins C, S and antithrombin and activated protein C resistance--their involvement in the occurrence of Arterial thromboses.

Authors:  Angela Mirela Soare; Constantin Popa
Journal:  J Med Life       Date:  2010 Oct-Dec

8.  Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost.

Authors:  Yu-Min Shen; Judy Tsai; Evelyn Taiwo; Chakri Gavva; Sean G Yates; Vivek Patel; Eugene Frenkel; Ravi Sarode
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

9.  Endovascular management of iliofemoral deep venous thrombosis due to iliac vein compression syndrome in patients with protein C and/or S deficiency.

Authors:  Yong Pil Cho; Je-Hong Ahn; Soo-Jung Choi; Myoung Sik Han; Hyuk Jai Jang; Yong Ho Kim; Hee Jeong Kim; Tae-Won Kwon; Sung Gyu Lee
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

10.  The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study.

Authors:  Daniela Tormene; Franco Noventa; Elena Campello; Sabrina Gavasso; Michelangelo Marobin; Giacomo Turatti; Paolo Prandoni; Paolo Simioni
Journal:  Intern Emerg Med       Date:  2021-02-22       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.